SUPN Stock Summary and Trading Ideas (Supernus Pharmaceuticals | NASDAQ:SUPN)

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Supernus Pharmaceuticals trades on the NASDAQ stock market under the symbol SUPN.

As of April 19, 2024, SUPN stock price climbed to $29.40 with 335,687 million shares trading.

SUPN has a beta of 0.92, meaning it tends to be less sensitive to market movements. SUPN has a correlation of 0.12 to the broad based SPY ETF.

SUPN has a market cap of $1.61 billion. This is considered a Small Cap stock.

Last quarter Supernus Pharmaceuticals reported $164 million in Revenue and $.39 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$.16.

In the last 3 years, SUPN stock traded as high as $42.09 and as low as $21.99.

The top ETF exchange traded funds that SUPN belongs to (by Net Assets): IJR, VTI, VB, IWM, VBR.

SUPN has underperformed the market in the last year with a price return of -19.0% while the SPY ETF gained +21.2%. However, in the short term, SUPN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +6.8% vs +4.3% return in SPY. But in the last 2 weeks, SUPN shares have been beat by the market, returning -11.6% compared to an SPY return of -3.5%.

SUPN support price is $28.01 and resistance is $29.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SUPN stock will trade within this expected range on the day.